TAG:
clinical integration
To Protect Pathology Profits: Understand Managed Care
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: On November 8, 1997, THE DARK REPORT convened a private symposium restricted only to pathologists. The sole purpose of this event was to identify how pathologists could preserve and enhance their income. Within the confidential setting of a plush resort in Scottsdale, Arizona…
“State of Lab Industry” Reveals Radical Change
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
CEO SUMMARY: Pick your trend: declining reimbursement, consolidation, clinical integration, downsizing, and capitated reimbursement. These trends all continued to shape the way laboratories organized to provide services. But 1997’s wildcard was the federal government. Between investigat…
UroCor, Inc.; Histology & AP.
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
UROCOR, INC. MATCHES THERAPEUTICS WITH DIAGNOSTICS With the recent signing of a co-promotion agreement with Zeneca Pharmaceuticals, UroCor, Inc. is positioned to offer therapeutics as a complement to its diagnostic testing. Based in Oklahoma City, UroCor is a fast-growing c…
Innovative Approach Promises Integration of Clinical Lab Data
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Any laboratory executive with several years in the business has confronted the limitations of laboratory information system (LIS) software. For a variety of reasons, LIS software seldom delivers the full range of benefits and cost-effectiveness sought by laboratories. But in …
Quest Diagnostics, Sonora Join Phoenix Operations
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: When Quest Diagnostics Incorporated and Sonora Laboratory Sciences announced their joint venture, it confirmed that Quest Diagnostics is the first of the national laboratories to begin serious restructuring of its national network of regional laboratories. Such restructuring …
Joint Venture In Phoenix To Be Copied Elsewhere
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
Pap Smear Technologies Battle For Market Share
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
Lab Information Systems Meeting Highlights Innovation, Ideas
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Managed care’s pressure to create clinically integrated healthcare delivery systems changes the way laboratories report, use and warehouse clinical data. Dr. Bruce Friedman’s annual laboratory information systems conference in Ann Arbor provided graphic evidence that tech…
New Features Slated For Lab Information Systems
By Robert Michel | From the Volume IV No. 5 – March 31, 1997 Issue
CEO SUMMARY: Two processes are transforming healthcare: managed care and quality management. Laboratory information systems must incorporate radically new features if they are to support changes to clinical laboratory operations. This makes it imperative that laboratory executives select …
Las Vegas Lab Gathering Debates Industry Trends
By Robert Michel | From the Volume IV No. 4 – March 10, 1997 Issue
CEO SUMMARY: Always a good forum for discussion of laboratory industry trends, this year’s meeting in Las Vegas addressed government regulation, laboratory automation and everything in between. Here is a brief rundown on some of the more interesting insights and observations….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized